68Ga-OncoCAIX

· Philogen S.p.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 68Ga-OncoCAIX, covering 2026-01-13 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoCAIX in Patients With CAIX-positive Cancer [Phase 1]